Literature DB >> 22771011

Within-subject consistency of sympathetic-skin-response waveform across different modalities of stimulation.

Minoru Toyokura1.   

Abstract

This study was conducted to investigate the intra-subject consistency of the waveform type and the size of the sympathetic skin response (SSR) evoked by different modalities of stimulation. Thirty-eight normal volunteers were enrolled as subjects. SSRs were obtained using three different modalities of stimulations: auditory (a-SSR), electrical (e-SSR), and magnetic (m-SSR). Four stimuli of each modality were applied. The waveforms were classified into two types, P (positive component larger the than negative component) and N (vice versa). P-type waveforms were less frequent in the a-SSR than in the e- and m-SSR. The occurrence of the respective waveforms and the values of maximum amplitudes were significantly correlated among the SSRs evoked by different types of stimulation. Judging from these results, the SSR waveforms and size seemed to be consistent in individuals. The results also suggested that endogenous factors in an individual related to the development of SSRs e.g., individual's emotional state, susceptibility to the surprise effect, and anatomical characteristic were important determinants of the SSR waveforms and maximum amplitude.
Copyright © 2012 Elsevier B.V. All rights reserved.

Mesh:

Year:  2012        PMID: 22771011     DOI: 10.1016/j.autneu.2012.06.003

Source DB:  PubMed          Journal:  Auton Neurosci        ISSN: 1566-0702            Impact factor:   3.145


  2 in total

1.  Pain Processing and Vegetative Dysfunction in Fibromyalgia: A Study by Sympathetic Skin Response and Laser Evoked Potentials.

Authors:  Marina de Tommaso; Katia Ricci; Giuseppe Libro; Eleonora Vecchio; Marianna Delussi; Anna Montemurno; Giuseppe Lopalco; Florenzo Iannone
Journal:  Pain Res Treat       Date:  2017-09-28

2.  Augmentation of the sympathetic skin response after electrical train stimuli.

Authors:  A Emmer; S Mangalo; M E Kornhuber
Journal:  Front Neurol       Date:  2012-10-30       Impact factor: 4.003

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.